Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Tipifarnib reduces the amount of activated Ras in precipitates compared to DMSO
regulating deubiquitination activity of USP10 and USP13 by Beclin1 provides a mechanism for Beclin1 to control the levels of p53
McGreivy J
selective and orally bioavailable GPR40 (FFA1) agonist
Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle
Tegaserod maleate Catalog No.:M8408-10 Tipifarnib reduces the amount ofTegaserod, also known as SDZ HTF 919; HTF 919 is a 5 HT4 agonist for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects. Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating, and constipation associated with
US$ 433.00
US$ 180.00
US$ 85.00
US$ 44.00
US$ 227.00
US$ 145.00
US$ 145.00
US$ 65.00
US$ 25.25
US$ 333.50
US$ 429.00